logo

For the Inventor, By the Inventor

Atherton, CA, United States of America

Jane E Shaw

USPTO Granted Patents = 13

Average Co-Inventor Count = 2.3

ph-index = 10

Forward Citations = 729(Granted Patents)


Company Filing History:

goldMedal13 out of 1,062 
 
Alza Corporation
 patents

Years Active: 1976-1994

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5286491 - Prevention of contact allergy by coadministration of a corticosteroid (1994-02-15),
2. 5171576 - Prevention of contact allergy by coadministration of a corticosteroid (1992-12-15),
3. 5077054 - Prevention of contact allergy by coadministration of a corticosteroid (1991-12-31),
4. 5000956 - Prevention of contact allergy by coadministration of a corticosteroid (1991-03-19),
5. 4846826 - Method for treating ischemic conditions (1989-07-11),
6. 4704119 - Method comprising transdermal and buccal treatment of angina (1987-11-03),
7. 4650484 - Method for treating ischemic conditions (1987-03-17),
8. 4486193 - Method for treating ischemic conditions by administering drug by two (1984-12-04),
9. 4436741 - Method for administering scopolamine transdermally (1984-03-13),
10. 4262003 - Method and therapeutic system for administering scopolamine transdermally (1981-04-14),
11. 4060084 - Method and therapeutic system for providing chemotherapy transdermally (1977-11-29),
12. 4031894 - Bandage for transdermally administering scopolamine to prevent nausea (1977-06-28),
13. 3932656 - Article of manufacture for instant release of anti-aggregation and (1976-01-13),

Title: Innovations by Jane E Shaw

Introduction

Jane E Shaw is a prominent inventor based in Atherton, CA (US). She has made significant contributions to the field of transdermal drug delivery, holding a total of 13 patents. Her work focuses on preventing contact allergies through innovative methods.

Latest Patents

Among her latest patents is a groundbreaking method for the prevention of contact allergy by coadministration of a corticosteroid. This method involves the inclusion of a corticosteroid that is coextensively coadministered with the sensitizing agent, effectively preventing sensitization in transdermal drug delivery.

Career Highlights

Jane E Shaw has established herself as a key figure in her field, working at Alza Corporation. Her expertise and innovative approaches have led to advancements in drug delivery systems, enhancing patient safety and treatment efficacy.

Collaborations

Throughout her career, Jane has collaborated with notable professionals, including John Urquhart and Robert M Gale. These partnerships have contributed to her success and the development of her patented technologies.

Conclusion

Jane E Shaw's contributions to the field of transdermal drug delivery are noteworthy, and her innovative methods continue to impact the industry positively. Her work exemplifies the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…